About this trial
The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.
Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?
Eligibility criteria
Qualifiers
aged 60 years and older
high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
receives reperfusion intervention.
Disqualifiers
Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
Incomplete medical records.
Trial design
Treatments tested in this trial
- Not listed